Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4H79Y | — |
only one patient that received the antigen alone; received the antigen alone; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number 4H79Y, expiry date 13-NOV-2026) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: only one patient that received the antigen alone) and inappropriate dose of vaccine administered (Verbatim: received the antigen alone). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 20-MAR-2025 On 20/Mar/2025, a nurse called to inform that it was discovered in a box of Shingrix that there were 3 vials left of Shingrix the vial that was left over out of the 3 was the gE antigen component. According to reporter, it was only one patient that received the antigen alone, and there were 9 suspect patients. No more information was provided by the reporter about this incident as it was unknown who the patient was. The Vaccine Administration Facility is the same as Primary Reporter. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.